Chitosan Oligosaccharides Attenuate Atherosclerosis and Decrease Non-HDL in ApoE-/- Mice
Authors:
- 1 January 2015
- journal article
- Published by Japan Atherosclerosis Society in Journal of Atherosclerosis and Thrombosis
- Vol. 22 (9) , 926-941
Abstract
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societiesKeywords
This publication has 24 references indexed in Scilit:
- Cardiovascular actions and therapeutic potential of tanshinone IIAAtherosclerosis, 2012
- Chitosan oligosaccharide decreases very-low-density lipoprotein triglyceride and increases high-density lipoprotein cholesterol in high-fat-diet-fed ratsExperimental Biology and Medicine, 2011
- Osteoarthritis accelerates and exacerbates Alzheimer's disease pathology in miceJournal of Neuroinflammation, 2011
- Anti-Inflammatory Activity of Chitooligosaccharides in VivoMarine Drugs, 2010
- Production of Chitooligosaccharides and Their Potential Applications in MedicineMarine Drugs, 2010
- Suppression of Metastasis of Human Breast Cancer Cells by Chitosan OligosaccharidesJournal of Microbiology and Biotechnology, 2009
- In vitro and in vivo degradation behavior of acetylated chitosan porous beadsJournal of Biomaterials Science, Polymer Edition, 2008
- EFFECTS OF SHRIMP (MACROBRACIUM ROSENBERGII)‐DERIVED CHITOSAN ON PLASMA LIPID PROFILE AND LIVER LIPID PEROXIDE LEVELS IN NORMO‐ AND HYPERCHOLESTEROLAEMIC RATSClinical and Experimental Pharmacology and Physiology, 2007
- Influence of molecular weight on oral absorption of water soluble chitosansJournal of Controlled Release, 2005
- Improvement of HDL- and LDL-Cholesterol Levels in Diabetic Subjects by Feeding Bread Containing ChitosanJournal of Medicinal Food, 2003